Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Brooke Sadler, Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, Sandra L Haberichter, Gabe Haller, Lilian Antunes, Veronica H Flood, Jorge Di Paola, Robert R Montgomery, The Zimmerman Program Investigators

Blood (2022) 140 (Supplement 1): 2753–2754.

https://doi.org/10.1182/blood-2022-163383

Published: 2022

Journal Articles

Rapid discrimination of the phenotypic variants of von Willebrand disease

Jonathan C. Roberts, Patti A. Morateck, Pamela A. Christopherson, Ke Yan, Raymond G. Hoffmann, Joan Cox Gill, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2016) 127 (20): 2472–2480.

https://doi.org/10.1182/blood-2015-11-664680

Published: 2016

Includes: Supplemental data

Journal Articles

Crucial role for the VWF A1 domain in binding to type IV collagen

Veronica H. Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi, Daniel B. Bellissimo, Pamela A. Christopherson, Kenneth D. Friedman, Joan Cox Gill, Raymond G. Hoffmann, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2015) 125 (14): 2297–2304.

https://doi.org/10.1182/blood-2014-11-610824

Published: 2015

Journal Articles

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Pamela A Christopherson, Veronica H Flood, MD, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R Montgomery, MD, Thomas C. Abshire, MD, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1510.

https://doi.org/10.1182/blood.V124.21.1510.1510

Published: 2014

Journal Articles

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Ashley Cartwright, PhD, Pamela A Christopherson, Crystal L. Perry, Sandra L Haberichter, PhD, Daniel Hampshire, PhD, Ian R. Peake, PhD, Anne Goodeve, PhD, Robert R Montgomery, MD, Daniel B. Bellissimo, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1525.

https://doi.org/10.1182/blood.V124.21.1525.1525

Published: 2014

Journal Articles

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

Jonathan C Roberts, Pamela A Christopherson, Patti A Morateck, Ke Yan, Raymond G Hoffmann, Joan Cox Gill, MD, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 4239.

https://doi.org/10.1182/blood.V124.21.4239.4239

Published: 2014

Journal Articles

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Kenneth D Friedman, MD, Rupa A Udani, PhD, Jonathan C Roberts, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 472.

https://doi.org/10.1182/blood.V124.21.472.472

Published: 2014

Journal Articles

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Joan Cox Gill, MD, Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Sandra L Haberichter, PhD, Rupa A Udani, PhD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 2829.

https://doi.org/10.1182/blood.V124.21.2829.2829

Published: 2014

Journal Articles

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

Veronica H. Flood, MD, Abraham C. Schlauderaff, Paula M. Jacobi, Tricia L. Slobodianuk, Robert R. Montgomery, MD, Sandra L. Haberichter, The Zimmerman Program Investigators

Blood (2013) 122 (21): 29.

https://doi.org/10.1182/blood.V122.21.29.29

Published: 2013

Journal Articles

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Sandra L. Haberichter, Pamela A. Christopherson, Veronica H. Flood, MD, Joan Cox Gill, MD, Daniel B. Bellissimo, Kenneth D Friedman, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 331.

https://doi.org/10.1182/blood.V122.21.331.331

Published: 2013

Journal Articles

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

Veronica H. Flood, MD, Joan Cox Gill, Sandra L. Haberichter, Daniel B Bellissimo, PhD, Pamela A Christopherson, Kenneth D Friedman, MD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 333.

https://doi.org/10.1182/blood.V122.21.333.333

Published: 2013

Journal Articles

A Novel Rapid Screening Assay for the Diagnosis of the Phenotypic Variants of Von Willebrand Disease (VWD)

Jonathan C Roberts, Patti A Morateck, Pamela A Christopherson, Ke Yan, Raymond G Hoffmann, Joan Cox Gill, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 3567.

https://doi.org/10.1182/blood.V122.21.3567.3567

Published: 2013

Journal Articles

Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD

Robert R. Montgomery, MD, Pamela A. Christopherson, Sandra L Haberichter, PhD, Veronica H Flood, MD, Joan Cox Gill, MD, The Zimmerman Program Investigators

Blood (2011) 118 (21): 381.

https://doi.org/10.1182/blood.V118.21.381.381

Published: 2011

Journal Articles

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

Sandra L Haberichter, PhD, Paula M Jacobi, BA, Veronica H Flood, MD, Pamela A. Christopherson, Joan Cox Gill, MD, Daniel B. Bellissimo, PhD, Kenneth D Friedman, MD, The Zimmerman Program Investigators

Blood (2011) 118 (21): 1215.

https://doi.org/10.1182/blood.V118.21.1215.1215

Published: 2011

Journal Articles

Bleeding Scores in Von Willebrand Disease (VWD) Re-Visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD

Joan Cox Gill, MD, Pamela A Christopherson, Veronica H Flood, MD, Kenneth D Friedman, MD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2008) 112 (11): 425.

https://doi.org/10.1182/blood.V112.11.425.425

Published: 2008

Journal Articles

Unique ELISA-Based Assays for VWF-GPIb Interactions and the Impact of Racial Differences on VWF Testing

Veronica H. Flood, MD, Patricia A. Morateck, Pamela A. Christopherson, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2008) 112 (11): 423.

https://doi.org/10.1182/blood.V112.11.423.423

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Rapid discrimination of the phenotypic variants of von Willebrand disease

Crucial role for the VWF A1 domain in binding to type IV collagen

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

A Novel Rapid Screening Assay for the Diagnosis of the Phenotypic Variants of Von Willebrand Disease (VWD)

Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

Bleeding Scores in Von Willebrand Disease (VWD) Re-Visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD

Unique ELISA-Based Assays for VWF-GPIb Interactions and the Impact of Racial Differences on VWF Testing

Email alerts

ASH Publications

American Society of Hematology